Protein Name: Rcf3 (Respiratory supercomplex factor 3)
Gene: YBR255C-A
UniProt ID: Q3E776
Molecular Weight: ~13.7 kDa
Localization: Mitochondrial inner membrane
Function:
Modulates oxygen flux through respiratory chain supercomplexes (III₂-IV₂)
Associates with monomeric cytochrome c oxidase and supercomplexes
Rcf3 deletion (rcf3Δ) increases oxygen flux through CIV by up to 25% without affecting growth on non-fermentable media .
Co-localizes with mitochondrial markers (MitoTracker) and associates with CIV-containing supercomplexes .
Works redundantly with Rcf2; double deletion (rcf2Δ/rcf3Δ) exacerbates defects in cytochrome c oxidase activity .
The YBR255C-A antibody has been utilized in:
Subcellular Localization Studies: GFP-tagged Rcf3 confirmed mitochondrial localization via fluorescence microscopy .
Supercomplex Profiling: Immunoprecipitation-MS identified Rcf3 in CIV-containing supercomplexes .
Quantitative Proteomics: Detected ~1,990 ± 1,107 copies/cell under standard growth conditions .
KEGG: sce:YBR255C-A
STRING: 4932.YBR255C-A
YBR255C-A (also known as Rcf3) is a gene in the yeast Saccharomyces cerevisiae that encodes a mitochondrial protein associated with respiratory chain supercomplexes. The YBR255C-A gene product was identified through proteomic analysis as a yeast mitochondrial membrane protein but was not initially characterized in detail . Subsequent research established its relationship to respiratory supercomplex factors, particularly as a homolog of the N-terminal portion of Rcf2 .
Methodologically, identification of YBR255C-A/Rcf3 typically involves:
Sequence analysis to identify homology with other proteins
Subcellular fractionation to isolate mitochondrial proteins
Proteomic analysis using mass spectrometry
Functional genomics approaches to determine association with respiratory chain components
YBR255C-A's significance lies in its role regulating mitochondrial respiratory function, making it an important target for understanding fundamental aspects of cellular energy metabolism.
YBR255C-A/Rcf3 shows exclusive localization to mitochondria, specifically in the inner mitochondrial membrane. This localization has been experimentally verified through fluorescence microscopy of living cells expressing Rcf3-GFP fusion proteins, which show co-localization with MitoTracker staining of mitochondria .
Computer-based analyses of the primary sequence of Rcf3 predict two transmembrane segments within the protein . This suggests Rcf3 is an integral membrane protein with domains that interact with respiratory chain components.
Methodologically, researchers determine localization through:
Creation of GFP fusion proteins expressed from authentic chromosomal loci
Live-cell fluorescence microscopy with mitochondrial co-staining
Subcellular fractionation followed by Western blotting
Protease protection assays to determine membrane topology
YBR255C-A/Rcf3 shares significant homology with the N-terminal region of Rcf2, while Rcf1 is homologous to the C-terminal portion of Rcf2 . This structural relationship suggests that Rcf2 may have evolved through fusion of ancestral proteins resembling Rcf3 and Rcf1.
The three proteins have overlapping but distinct roles in respiratory chain function:
Rcf1 primarily modulates cytochrome c oxidase activity, maintaining the dominant population in a functionally active state
Rcf3 (YBR255C-A) associates with supercomplexes predominantly via complex IV
Experimental approaches to study these relationships include sequence analysis, functional complementation studies, and phenotypic analysis of single and multiple gene deletion strains.
Several complementary techniques have proven effective for detecting and studying YBR255C-A/Rcf3:
Fluorescence microscopy: GFP fusion proteins have successfully visualized Rcf3 localization in mitochondria
Western blotting: Affinity capture-Western techniques have demonstrated interactions between YBR255C-A and other proteins
Blue Native PAGE (BN-PAGE): Effective for analyzing association with respiratory chain supercomplexes
Mass spectrometry: For identification and quantification in complex mitochondrial samples
Methodological considerations when working with YBR255C-A include:
Selection of appropriate detergents for solubilization that maintain native interactions
Use of proper controls (knockout strains) for antibody validation
Careful preparation of mitochondrial fractions to preserve supercomplex integrity
Affinity Capture-Western has been successfully used to demonstrate the interaction between YBR255C-A and Rcf1 . This technique involves:
Affinity capture of bait proteins from cell extracts using antibodies or epitope tags
Identification of interaction partners by Western blot analysis
Verification using specific antibodies or secondary epitope tags
Additional approaches for characterizing YBR255C-A interactions include:
Co-immunoprecipitation with mitochondrial components
Crosslinking mass spectrometry to identify interaction interfaces
Proximity labeling techniques (BioID, APEX) to identify proteins in the vicinity
Two-dimensional electrophoresis to analyze complex composition
Proper experimental design should include appropriate controls and consideration of detergent conditions that preserve native interactions.
Several genetic approaches have been successfully employed for YBR255C-A/Rcf3 research:
Gene deletion: Single deletion (rcf3Δ) and double deletion with Rcf2 (rcf2Δ/rcf3Δ) have revealed functional redundancy between these proteins
Epitope tagging: C-terminal GFP tagging has been used to visualize Rcf3 localization while preserving function
Expression from natural loci: Expression of tagged proteins from authentic chromosomal loci maintains natural expression patterns
Methodological considerations for genetic manipulations include:
Assessment of tag effects on protein function
Verification of correct integration and expression
Use of appropriate promoters to maintain physiological expression levels
Creation of conditional alleles for essential functions
Deletion of YBR255C-A/Rcf3 produces specific phenotypes related to mitochondrial function:
Increased oxygen flux through complex IV (cytochrome c oxidase)
No growth defect on non-fermentable medium, indicating functional respiration is maintained
More pronounced effects in double deletion strains (rcf2Δ/rcf3Δ) compared to single deletions, suggesting functional redundancy
These observations suggest YBR255C-A/Rcf3 plays a regulatory role in controlling electron transfer efficiency rather than being absolutely required for supercomplex formation.
Methodological approaches for phenotypic analysis typically include:
Growth assays on fermentable versus non-fermentable carbon sources
Oxygen consumption measurements using respirometry
Spectroscopic analysis of cytochrome spectra
Blue native gel electrophoresis to assess supercomplex assembly
YBR255C-A/Rcf3 associates with respiratory chain supercomplexes, predominantly via complex IV (cytochrome c oxidase) . Both Rcf3 and the C-terminal fragment of Rcf2 associate with monomeric cytochrome c oxidase and respiratory chain supercomplexes .
The contribution of YBR255C-A/Rcf3 to supercomplex assembly appears to be regulatory rather than structural. Its deletion increases oxygen flux through the respiratory chain without disrupting supercomplex formation entirely , suggesting a role in fine-tuning electron transfer efficiency.
Experimental approaches to investigate supercomplex dynamics include:
Blue native PAGE analysis of digitonin-solubilized mitochondria
In-gel activity assays for respiratory complexes
Kinetic analysis of respiratory chain activity
Crosslinking studies to identify interaction interfaces
YBR255C-A/Rcf3 influences the activity of cytochrome c oxidase, as evidenced by increased oxygen flux in deletion strains . This suggests it may modulate the enzyme's catalytic efficiency or regulate electron transfer between respiratory complexes.
While the precise mechanism remains to be fully elucidated, studies on the related protein Rcf1 provide insight into possible regulatory mechanisms. Rcf1 has been shown to maintain cytochrome c oxidase in a functionally active state, especially under high respiratory chain workload . Cytochrome c oxidase exists in three structurally different populations, and Rcf1 maintains the dominant population in a functionally active state .
Given the relationship between YBR255C-A/Rcf3 and other Rcf proteins, it likely contributes to similar regulatory processes, potentially affecting different populations or functional states of cytochrome c oxidase.
Differentiating between the functions of these related proteins requires sophisticated experimental approaches:
Comparative phenotypic analysis: Systematic characterization of single, double, and triple deletion strains under various conditions
Domain swapping experiments: Creation of chimeric proteins containing domains from different Rcf proteins to map functional regions
Complementation studies: Testing whether expression of one protein can rescue phenotypes caused by deletion of another
Structural analysis: Using the homology relationship between these proteins (Rcf3 resembles Rcf2's N-terminus; Rcf1 resembles Rcf2's C-terminus) to investigate structure-function relationships
Differential interaction mapping: Identifying unique binding partners for each protein
Current research indicates distinct but overlapping roles:
Rcf2 undergoes maturation into N- and C-terminal peptides with distinct functions
Rcf3 (YBR255C-A) has an overlapping role with Rcf2, particularly in regulating oxygen flux through complex IV
Developing specific antibodies against YBR255C-A/Rcf3 presents several technical challenges:
Limited epitope selection: The protein's small size and transmembrane domains restrict accessible, immunogenic regions
Cross-reactivity concerns: Sequence homology with Rcf2's N-terminal region increases the risk of antibody cross-reactivity
Validation challenges: Confirming specificity requires careful controls including knockout strains
Methodological approaches to address these challenges include:
Epitope selection strategies:
Target unique regions that differ from Rcf2
Use peptide immunogens from hydrophilic regions
Consider recombinant fragments expressed in bacterial systems
Validation protocols:
Western blot analysis comparing wild-type and rcf3Δ strains
Cross-reactivity testing against purified Rcf1 and Rcf2
Pre-absorption tests with immunizing peptides
Immunoprecipitation followed by mass spectrometry
Alternative approaches:
Epitope tagging strategies (HA, FLAG) when antibodies prove challenging
Using fluorescent protein fusions for localization studies
Investigating post-translational modifications (PTMs) of YBR255C-A/Rcf3 requires specialized approaches:
Mass spectrometry-based proteomics:
Enrichment strategies for specific modifications (phosphorylation, acetylation)
High-resolution MS/MS for precise mapping of modification sites
Quantitative approaches to determine stoichiometry of modifications
Site-directed mutagenesis:
Mutation of potential modification sites to non-modifiable residues
Creation of phosphomimetic mutations to simulate constitutive modification
Assessment of functional consequences through phenotypic analysis
In vitro modification assays:
Testing candidate modifying enzymes with purified YBR255C-A/Rcf3
Reconstitution experiments with modified and unmodified protein
Temporal analysis:
Investigation of modification patterns under different metabolic conditions
Stress response analysis to identify regulatory modifications
Special considerations for YBR255C-A/Rcf3 include: